Accolade
Plymouth Meeting, US · Founded 2010 · Delaware corporation · 14 known investors
Accolade provides virtual healthcare services including primary care, mental health therapy, and benefits navigation for employees and their families. The platform connects members with doctors, therapists, and care advocates to simplify healthcare access and decision-making.
Digital HealthHealthtechSaaS
Founders & leadership
SB
Sheila BurkeDirector
MT
Michael T. YangDirector
SB
Steve BarnesExecutive Officer
TJ
Thomas J. NeffDirector
JM
J. Michael ClineDirector
JW
John W. RoweDirector
JC
James C. Madden, VDirector
WF
William Frist, Sr.Director
MM
Mark MactasDirector
TK
Thomas K SpannExecutive Officer, Director
RS
Rajeev SinghChief Executive Officer
DC
Debbie CohenExecutive Officer
Investors · 14
7wire VenturesChicago · $100K – $5M
Accretive, LLCNew York
Alumni VenturesManchester · $100K – $10M
Andreessen HorowitzMenlo Park · $500K – $50Mvia Jeff Jordan · board
Basecamp FundManchester · $100K – $10M
Blue Ivy VenturesBoston
Carrick Capital PartnersSan Francisco
Castor Ventures (an Alumni Ventures Fund)
Comcast VenturesNew York · $2M – $15M
Cross Creek AdvisorsSalt Lake City
Escalate Capital PartnersAustin
Madrona Venture GroupSeattle · $2M – $10M
McKesson VenturesSan Francisco
Strawberry Creek VenturesManchester
Reported raises · per SEC filings
Form D private placements▶$11.3MraisedOct 2021 · 1 investors · Other Health CareRule 506(b)
▶$11.3MraisedOct 2021 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Patricia WadorsDirector
- Elizabeth NabelDirector
- Cindy KentDirector
- Peter KleinDirector
- Jeff JordanDirector
- Robert CavanaughExecutive Officer
- Michael HiltonExecutive Officer
- Rajeev SinghExecutive Officer, Director
- Jeffrey BrodskyDirector
- Stephen BarnesExecutive Officer
- Thomas J. NeffDirector
- Dawn LeporeDirector
- Offering amount
- $12.5M
- Amount sold
- $11.3M
- First sale
- Sep 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$325.3MraisedJun 2021 · 79 investors · Other Health CareRule 506(b)
▶$325.3MraisedJun 2021 · 79 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Cindy KentDirector
- Rajeev SinghExecutive Officer, Director
- Jeff BrodskyDirector
- Stephen BarnesExecutive Officer
- Jeff JordanDirector
- Dawn LeporeDirector
- Robert CavanaughExecutive Officer
- Elizabeth NabelDirector
- Michael HiltonExecutive Officer
- Thomas J. NeffDirector
- Peter KleinDirector
- Patricia WadorsDirector
- Offering amount
- $390.4M
- Amount sold
- $325.3M
- First sale
- Jun 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$130MraisedMar 2021 · 43 investors · Other Health CareRule 506(b)
▶$130MraisedMar 2021 · 43 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Thomas J. NeffDirector
- Cindy KentDirector
- J. Michael ClineDirector
- Peter KleinDirector
- Patricia WadorsDirector
- William Frist, Sr.Director
- Dawn LeporeDirector
- Stephen BarnesExecutive Officer
- Jeff JordanDirector
- Robert CavanaughExecutive Officer
- Michael HiltonExecutive Officer
- Rajeev SinghExecutive Officer, Director
- Offering amount
- $230M
- Amount sold
- $130M
- First sale
- Mar 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$20MraisedOct 2019 · 1 investors · Other Health CareRule 506(b)
▶$20MraisedOct 2019 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Edgar Bronfman, Jr.Director
- James C. Madden, VDirector
- J. Michael ClineDirector
- Peter KleinDirector
- Michael T. YangDirector
- Thomas J. NeffDirector
- Dawn LeporeDirector
- Stephen BarnesExecutive Officer
- Jeff JordanDirector
- Rajeev SinghExecutive Officer, Director
- Mike HiltonExecutive Officer
- William Frist, Sr.Director
- Richard EskewExecutive Officer
- Robert CavanaughExecutive Officer
- Offering amount
- $20M
- Amount sold
- $20M
- First sale
- Oct 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$27.2MraisedMar 2018 · 17 investors · Other Health CareRule 506(b)
▶$27.2MraisedMar 2018 · 17 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Michael T. YangDirector
- J. Michael ClineDirector
- Edgar Bronfman, Jr.Director
- Robert CavanaughExecutive Officer
- Jeff JordanDirector
- Thomas K SpannExecutive Officer, Director
- James C. Madden, VDirector
- Ivor HornExecutive Officer
- Mark MactasDirector
- Stephen BarnesExecutive Officer
- Dave SwiftExecutive Officer
- Thomas J. NeffDirector
- Rajeev SinghExecutive Officer, Director
- Elizabeth NapolitanoExecutive Officer
- William Frist, Sr.Director
- Richard EskewExecutive Officer
- Mike HiltonExecutive Officer
- Offering amount
- $50M
- Amount sold
- $27.2M
- First sale
- Mar 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$55MraisedAug 2016 · 4 investors · Other Health CareRule 506(b)
▶$55MraisedAug 2016 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jeff JordanDirector
- Mark MactasDirector
- Sheila BurkeDirector
- James C. Madden, VDirector
- Michael T. YangDirector
- Thomas K SpannExecutive Officer, Director
- Stephen BarnesExecutive Officer
- Thomas J. NeffDirector
- J. Michael ClineDirector
- Edgar Bronfman, Jr.Director
- William Frist, Sr.Director
- Rajeev SinghExecutive Officer, Director
- Offering amount
- $60M
- Amount sold
- $55M
- First sale
- Jul 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$38.6MraisedDec 2015 · 5 investors · Other Health CareRule 506(b)
▶$38.6MraisedDec 2015 · 5 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Sheila BurkeDirector
- Michael T. YangDirector
- Steve BarnesExecutive Officer
- Thomas J. NeffDirector
- J. Michael ClineDirector
- John W. RoweDirector
- James C. Madden, VDirector
- William Frist, Sr.Director
- Mark MactasDirector
- Thomas K SpannExecutive Officer, Director
- Rajeev SinghExecutive Officer, Director
- Debbie CohenExecutive Officer
- Edgar Bronfman, Jr.Director
- Offering amount
- $53.6M
- Amount sold
- $38.6M
- First sale
- Jul 2015
- Incorporated
- Corporation, Delaware, 2010
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Acquisitions · 1
Early investors' stakes continue via these dealsHealthReveal
Identifies gaps in evidence-based care and guides clinicians to appropriate interventions; acquired by Accolade.
In the news
- LimX Dynamics Raises Nearly $200 Million In Pre-IPO Funding To Scale Humanoid Robotspulse2.com · 2026
- China's DeepSeek to raise fresh capital at $74 billion valuation ahead of onshore IPO - The Economic Timesm.economictimes.com · 2026
- Caliber Mining’s ₹450 crore IPO opens today; raises ₹135 crore from anchor investors ahead of issuefortuneindia.com · 2026
- London Broker Howden Plots Giant Capital Raise on IPO Path - Bloombergbloomberg.com · 2026
- Space startup funding holds near record highs as SpaceX IPO draws new investors | 101 WIXX | Your Hit Music Stationwixx.com · 2026
- SBI Funds raises Rs 2,663 crore from anchor investors ahead of IPO - The Economic Timesm.economictimes.com · 2026
- What pandemic? Tech funding stays strong, Accolade’s IPOgeekwire.com · 2020